Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma

By                

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 93-99

Science Publishers

Access to resources Recommend Favorite

Effect of the cytokine levels in serum on osteosarcoma

By Xiao Hong   Chen Ling   Luo Gang   Son Haihang   Prectoni James   Zheng Wenjie  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1023-1028

Springer Publishing Company

Access to resources Recommend Favorite

Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

By Filippi Andrea Riccardo  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1183-1187

Informa Healthcare

Access to resources Recommend Favorite

Impact of Highly Active Antiretroviral Therapy in the Treatment of HIV-Infected Patients with Systemic Non-Hodgkin's Lymphoma

By Baiocchi Otavio C. G.   Colleoni Gisele W. B.   Navajas Eduardo V.   Duarte Luiz Claudio C.   Alves Antonio C.   Andrade Ana Lucia S. S.   Kerbauy Jose   Oliveira Jose Salvador R.  

Acta Oncologica, Vol. 41, Iss. 2, 2002-04 ,pp. : 192-196

Informa Healthcare

Access to resources Recommend Favorite

Bendamustine pharmacokinetic profile and exposure–response relationships in patients with indolent non-Hodgkin’s lymphoma

By Owen Joel   Melhem Murad   Passarell Julie   D’Andrea Denise   Darwish Mona   Kahl Bradley  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1039-1049

Springer Publishing Company

Access to resources Recommend Favorite